Skip to main content
. 2022 Jan 20;13(2):152. doi: 10.3390/mi13020152

Figure 7.

Figure 7

Selected microfluidic platforms constructed to aid the development of modern drug and biological anticancer treatments of breast cancer, which are classified in six modalities: cytostatic drugs, small-molecule inhibitors, monoclonal antibodies (MAbs), chimeric antigen-specific receptor transfected T cells (CAR-Ts), virotherapy, and vaccine therapy.